CYTOTOXIC AND CYTOSTATIC EFFECTS OF ANTITUMOR AGENTS INDUCED AT THE PLASMA-MEMBRANE LEVEL

被引:40
作者
GRUNICKE, H
HOFMANN, J
机构
[1] Institute for Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck
基金
奥地利科学基金会;
关键词
D O I
10.1016/0163-7258(92)90027-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A variety of antitumor agents inhibit cell proliferation by interacting with the plasma membrane. They act as growth factor antagonists, growth factor receptor blockers, interfere with mitogenic signal transduction or exert direct cytotoxic effects. The P-glycoprotein encoded by the MDR1 gene represents a transmembrane protein which catalyzes the efflux of various antitumor agents. This membrane protein is the target of compounds acting as Multi-Drug Resistance (MDR)-modulators. Finally, several established antitumor agents which are considered to represent DNA-targeted drugs, including anthracyclines, platinum complexes and alkylating agents, cause a variety of membrane lesions. Their contribution to the antitumor activity of these drugs is discussed.
引用
收藏
页码:1 / 30
页数:30
相关论文
共 306 条
[71]   MEMBRANE-RECEPTORS FOR PEPTIDES IN EXPERIMENTAL AND HUMAN PANCREATIC CANCERS [J].
FEKETE, M ;
ZALATNAI, A ;
COMARUSCHALLY, AM ;
SCHALLY, AV .
PANCREAS, 1989, 4 (05) :521-528
[72]  
FENDLY BM, 1990, CANCER RES, V50, P1550
[73]   TUMOR-NECROSIS-FACTOR - CHARACTERIZATION AT THE MOLECULAR, CELLULAR AND INVIVO LEVEL [J].
FIERS, W .
FEBS LETTERS, 1991, 285 (02) :199-212
[74]  
FINE RL, 1986, P AM ASSOC CANC RES, V27, P271
[75]   PHORBOL ESTERS INDUCE MULTIDRUG RESISTANCE IN HUMAN-BREAST CANCER-CELLS [J].
FINE, RL ;
PATEL, J ;
CHABNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :582-586
[76]   REQUIREMENT FOR IFN-GAMMA IN POTENTIATION OF INTERFERONS ANTIVIRAL AND ANTICELLULAR ACTIVITIES - IDENTITY OF MOUSE AND HUMAN SYSTEMS [J].
FLEISCHMANN, WR ;
SCHWARZ, LA ;
FLEISCHMANN, CM .
JOURNAL OF INTERFERON RESEARCH, 1984, 4 (02) :265-274
[77]   PROGNOSTIC VALUE OF PS2 PROTEIN AND RECEPTORS FOR EPIDERMAL GROWTH-FACTOR (EGF-R), INSULIN-LIKE GROWTH FACTOR-I (IGF-1-R) AND SOMATOSTATIN (SS-R) IN PATIENTS WITH BREAST AND OVARIAN-CANCER [J].
FOEKENS, JA ;
VANPUTTEN, WLJ ;
PORTENGEN, H ;
RODENBURG, CJ ;
REUBI, JC ;
BERNS, PMJJ ;
HENZENLOGMANS, SC ;
VANDERBURG, MEL ;
ALEXIEVAFIGUSCH, J ;
KLIJN, JGM .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06) :815-821
[78]  
FOON KA, 1989, CANCER RES, V49, P1621
[79]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[80]  
FORD JM, 1989, MOL PHARMACOL, V35, P105